Balanced news tone
News Sentiment
NTRB sentiment intelligence
Nutriband Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, -12.7% over four weeks, trend inactive, and below fair value.
Nutriband Inc. (NTRB) Slips 2.33% as Stock Tests Key Support at $2.79 - Sweep Order Flow
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Nutriband Inc. (NTRB) Slips 2.33% as Stock Tests Key Support at $2.79 - Sweep Order Flow
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 14:48
- Source
- dars.gov.et
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
[8-K] NutriBand Inc. Reports Material Event | NTRB 8-K Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
NutriBand Secures Amended Three-Year $5 Million Credit Line at 7% to Support AVERSA
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 22 Jun 2026 07:00
- Source
- TradingView
Nutriband Inc (NTRB) Institutional Confidence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:56
- Source
- TradingKey
Nutriband Inc. (NTRB) Slips Modestly as Stock Tests Key Support Levels - Rating Change
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 09 Jun 2026 07:00
- Source
- DonanımHaber
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 11:00
- Source
- GlobeNewswire
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 11:00
- Source
- GlobeNewswire
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- GlobeNewswire
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- Market source
Nutriband responds to Trump’s designation of illicit fentanyl as WMD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Dec 2025 08:00
- Source
- Investing.com
Nutriband (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 11 Sep 2025 07:00
- Source
- The Globe and Mail
Nutriband CEO Gareth Sheridan: “The economy is booming, but that’s a punch to the gut – when we’re a top 5 performer in every major index but our own people can’t afford to live here
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Aug 2025 07:00
- Source
- Hotpress
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 Jul 2025 07:00
- Source
- Market source
What is the current Price Target and Forecast for Nutriband (NTRB)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 02 Dec 2022 22:08
- Source
- Zacks Investment Research
Nutriband (NTRB) Stock Price, News & Analysis $NTRB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Aug 2022 17:37
- Source
- MarketBeat
Nutriband Stock Price Forecast. Should You Buy NTRB?
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 14 Oct 2021 20:39
- Source
- StockInvest.us
Should I buy Nutriband (NTRB)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Oct 2020 20:37
- Source
- Zacks Investment Research